Tyra Biosciences Stock Analysis

Tyra Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.5. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tyra Biosciences has Price/Earnings To Growth (PEG) ratio of 0.28. The entity recorded a loss per share of 1.61. The firm had not issued any dividends in recent years. Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California. Tyra Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people. To find out more about Tyra Biosciences contact the company at 619 728 4760 or learn more at https://tyra.bio.

Tyra Biosciences Investment Alerts

Tyra Biosciences Upcoming and Recent Events

Tyra Largest EPS Surprises

View All Earnings Estimates

Tyra Biosciences Environmental, Social, and Governance (ESG) Scores

Tyra Stock Institutional Investors

Note, although Tyra Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tyra Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 540.95 M.

Tyra Profitablity

Management Efficiency

Tyra Biosciences has return on total asset (ROA) of (0.2021) % which means that it has lost $0.2021 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2866) %, meaning that it created substantial loss on money invested by shareholders. Tyra Biosciences' management efficiency ratios could be used to measure how well Tyra Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of March 23, 2025, Return On Tangible Assets is expected to decline to -0.29. The current year's Return On Capital Employed is expected to grow to -0.41. At present, Tyra Biosciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 7.3 M, whereas Total Assets are forecasted to decline to about 179.4 M.

Technical Drivers

As of the 23rd of March, Tyra Biosciences has the Coefficient Of Variation of (756.09), variance of 11.55, and Risk Adjusted Performance of (0.11). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tyra Biosciences, as well as the relationship between them.

Tyra Biosciences Price Movement Analysis

Tyra Biosciences Insider Trading Activities

Tyra Biosciences Outstanding Bonds

Tyra Biosciences Predictive Daily Indicators

Tyra Biosciences Corporate Filings

Tyra Biosciences Forecast Models

Tyra Biosciences' time-series forecasting models are one of many Tyra Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tyra Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tyra Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tyra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tyra Biosciences. By using and applying Tyra Stock analysis, traders can create a robust methodology for identifying Tyra entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tyra analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tyra analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tyra Biosciences stock analysis indicators help investors evaluate how Tyra Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tyra Biosciences shares will generate the highest return on investment. By understating and applying Tyra Biosciences stock analysis, traders can identify Tyra Biosciences position entry and exit signals to maximize returns.

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.